GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Pola Orbis Holdings Inc (OTCPK:PORBF) » Definitions » Quality Rank

Pola Orbis Holdings (Pola Orbis Holdings) Quality Rank


View and export this data going back to 2014. Start your Free Trial

What is Pola Orbis Holdings Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Pola Orbis Holdings Quality Rank Related Terms

Thank you for viewing the detailed overview of Pola Orbis Holdings's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Pola Orbis Holdings (Pola Orbis Holdings) Business Description

Traded in Other Exchanges
Address
2-2-3 Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Pola Orbis Holdings Inc is a beauty and health company. The company has a multibrand and multichannel strategy, being engaged in mail-order sales (online and catalog) and retail-store sales. The business divisions comprise the beauty care business, the real estate business, and others. The beauty care business, generating more than 90% of sales, has two main brands--Pola and Orbis--which are sold internationally. The real estate business leases office buildings, while the others segment is engaged in development of pharmaceutical and dermatological products.